Prevalence and Factors Associated with Depression, Anxiety and Stress in IBD Patients Undergoing Intravenous Biological Therapy during the COVID-19 Pandemic-Montenegro Experience

作     者：Brigita Smolović MarijaĐurović MilošLukić Marija Abramović Damir Muhović 

作者机构：Department of GastroenterohepatologyClinic for Internal MedicineClinical Center of MontenegroPodgorica81000Montenegro Faculty of MedicineUniversity of MontenegroPodgorica81000Montenegro Clinic of RadiologyClinical Center of MontenegroPodgorica81000Montenegro 

出 版 物：《International Journal of Mental Health Promotion》 (国际心理健康促进杂志（英文）)

年 卷 期：2022年第24卷第4期

页      面：551-564页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Inflammatory bowel disease depression anxiety stress COVID-19 

摘      要：Throughout its duration,the coronavirus disease 2019(COVID-19)pandemic has been affecting lives worldwide and has had a sizeable impact on mental health,particularly for those who already suffer from a chronic ***,Anxiety and Stress(DAS)are common psychiatric comorbidities in inflammatory bowel disease(IBD)*** study aims to determine the prevalence and risk factors for moderate and severe symptoms of DAS in IBD patients have been undergoing intravenous biological therapy(IvBTh)during the COVID-19 *** study was conducted between September 1st and November 30th,2020 at the Clinical Center of Mon-tenegro-IBD unit,where all patients from Montenegro received the registered *** case control study consists of 94 IBD patients that completed a validated questionnaire Depression,Anxiety and Stress Score-21(DASS-21).A total of 59 patients received tumor necrosis factor alpha inhibitors(anti-TNF therapy),while 35 received anti-integrin *** we calculated the DASS-21 score,we divided the patients into two groups:those who had moderate and severe symptoms(if they had any of the mentioned DASS-21 subscale score above limit for moderate or more severe symptoms:DASS-21 Depression,higher than 14;DASS-21 Anxiety,higher than 10 and DASS-21 Stress,higher than 19)and those who did not have significant symptoms(DASS-21 subscale score did not exceed the limit).We also examined demographic data,data on IBD characteristics and COVID-19 data and their impact on mental *** statistical processing tests were used to identify risk factors for examined mental *** the DASS-21 criteria,we diagnosed the least moderate depression in 19.1%,anxiety in 14.9%and stress in 20.2%*** multivariate analysis indicated there to be a statistically significant relation of being higher at risk of developing depression,anxiety and stress when suffering from an active form of IBD(OR 6.487;95%Cl 1.220–34.500,P=0.028).Almost one t